AbbVie Reports the US FDA’s Approval of Botox Cosmetic (OnabotulinumtoxinA) for Moderate to Severe Vertical Bands Connecting the Jaw and Neck
Shots:
- The US FDA has approved Allergan Aesthetics’ (AbbVie company) Botox Cosmetic to temporarily enhance the appearance of moderate to severe platysma bands (vertical bands joining the jaw & neck) in adults
- Approval was based on the P-III trials of Botox cosmetic (26, 31 or 36 units) vs PBO which achieved the 1EP showing 32% vs 2% (study 1) & 31% vs 0% (study 2) multi-component ≥2-grade improvement in Platysma Band Severity and 65% & 62% vs 12% of them were satisfied with neck & jawline definition at D14
- Botox Cosmetic is a neurotoxin approved to enhance moderate to severe platysma bands, along with forehead lines, frown lines & crow's feet
Ref: Abbvie | Image: Abbvie
Related News:- AbbVie Reports the US FDA’s Approval of Vyalev (Foscarbidopa and Foslevodopa) for Treating Advanced Parkinson's Disease
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
